Mingjing Shen

941 total citations
29 papers, 656 citations indexed

About

Mingjing Shen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mingjing Shen has authored 29 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Mingjing Shen's work include Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and MicroRNA in disease regulation (4 papers). Mingjing Shen is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and MicroRNA in disease regulation (4 papers). Mingjing Shen collaborates with scholars based in China and United States. Mingjing Shen's co-authors include Kanqiu Jiang, Weihua Xu, Yongbing Chen, Soo Ok Lee, Yuhchyau Chen, Ying Tsai, Peter C. Keng, Fuquan Zhang, Zhonghua Xu and Qifeng Ding and has published in prestigious journals such as Cancer Research, Scientific Reports and Chemosphere.

In The Last Decade

Mingjing Shen

29 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingjing Shen China 12 308 253 183 175 100 29 656
Ruoqin Wang China 9 359 1.2× 204 0.8× 167 0.9× 288 1.6× 112 1.1× 12 667
Francesca Maria Consonni Italy 12 218 0.7× 290 1.1× 448 2.4× 136 0.8× 64 0.6× 18 684
Umar Raza China 14 407 1.3× 153 0.6× 50 0.3× 296 1.7× 88 0.9× 21 627
Chunping Qiu China 19 432 1.4× 119 0.5× 128 0.7× 282 1.6× 83 0.8× 31 741
Xinzhou Deng China 13 298 1.0× 136 0.5× 137 0.7× 135 0.8× 72 0.7× 26 470
Peter Breslin United States 16 424 1.4× 84 0.3× 176 1.0× 184 1.1× 39 0.4× 34 737
Bethany Smith United States 10 530 1.7× 360 1.4× 66 0.4× 274 1.6× 168 1.7× 16 863
Xiaoqian Jing China 19 442 1.4× 185 0.7× 105 0.6× 221 1.3× 94 0.9× 32 680
Chuanyong Zhang China 13 382 1.2× 156 0.6× 125 0.7× 231 1.3× 49 0.5× 25 630

Countries citing papers authored by Mingjing Shen

Since Specialization
Citations

This map shows the geographic impact of Mingjing Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjing Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjing Shen more than expected).

Fields of papers citing papers by Mingjing Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjing Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjing Shen. The network helps show where Mingjing Shen may publish in the future.

Co-authorship network of co-authors of Mingjing Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjing Shen. A scholar is included among the top collaborators of Mingjing Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjing Shen. Mingjing Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoyu, Pi Ding, Jing Ren, et al.. (2025). Distinct CTC Specific RNA Profile Enables NSCLC Early Detection and Dynamic Monitoring of Advanced NSCLC. Advanced Science. 12(23). e2417849–e2417849. 1 indexed citations
2.
Xu, Yiming, et al.. (2025). MISP Suppresses Ferroptosis via MST1/2 Kinases to Facilitate YAP Activation in Non‐Small Cell Lung Cancer. Advanced Science. 12(16). e2415814–e2415814. 6 indexed citations
3.
Li, Jiaxin, et al.. (2025). TIMM23 overexpression drives NSCLC cell growth and survival by enhancing mitochondrial function. Cell Death and Disease. 16(1). 174–174. 2 indexed citations
4.
Chen, Huilin, et al.. (2024). Detection of 6-PPD and 6-PPDQ in airborne particulates and assessment of their toxicity in lung cells. Chemosphere. 364. 143205–143205. 11 indexed citations
5.
Sun, Dantong, Yongbing Chen, Qiang Yuan, et al.. (2024). CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis. Journal of Experimental & Clinical Cancer Research. 43(1). 202–202. 11 indexed citations
6.
Jiang, Kanqiu, Shasha Liu, Yongbing Chen, et al.. (2023). Characterization of TCF‐1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients. Thoracic Cancer. 14(27). 2745–2753. 3 indexed citations
7.
Jiang, Kanqiu, et al.. (2022). Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth. Cell Death and Disease. 13(7). 602–602. 27 indexed citations
8.
Ma, Kaili, Lina Sun, Mingjing Shen, et al.. (2022). Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8+ T cell exhaustion. iScience. 25(5). 104347–104347. 15 indexed citations
9.
Shen, Mingjing, Kanqiu Jiang, Zhonghua Xu, et al.. (2021). Characterization of CD66b and its relationship between immune checkpoints and their synergistic impact in the prognosis of surgically resected lung adenocarcinoma. Lung Cancer. 160. 84–91. 7 indexed citations
10.
Shen, Mingjing, Zhonghua Xu, Weihua Xu, et al.. (2019). Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 149–149. 157 indexed citations
11.
Jiang, Kanqiu, Ting Zhao, Mingjing Shen, et al.. (2019). MiR-940 inhibits TGF-β-induced epithelial-mesenchymal transition and cell invasion by targeting Snail in non-small cell lung cancer. Journal of Cancer. 10(12). 2735–2744. 22 indexed citations
12.
Li, Xiaoting, Teng Ma, Jiacheng Sun, et al.. (2019). Harnessing the secretome of adipose-derived stem cells in the treatment of ischemic heart diseases. Stem Cell Research & Therapy. 10(1). 196–196. 39 indexed citations
13.
14.
Zhu, Rongying, Xiang Xue, Mingjing Shen, et al.. (2018). NFκB and TNFα as individual key molecules associated with the cisplatin-resistance and radioresistance of lung cancer. Experimental Cell Research. 374(1). 181–188. 9 indexed citations
15.
Xu, Lijun, Mingjing Shen, Xiaohong Chen, et al.. (2018). In vitro -induced M2 type macrophages induces the resistance of prostate cancer cells to cytotoxic action of NK cells. Experimental Cell Research. 364(1). 113–123. 10 indexed citations
16.
17.
18.
Li, Yang, Mingjing Shen, Li Xu, et al.. (2017). Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK/Erk signaling inhibition. Scientific Reports. 7(1). 7958–7958. 44 indexed citations
19.
Xu, Weihua, Kanqiu Jiang, Mingjing Shen, Yongbing Chen, & Haoyue Huang. (2015). Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150. Oncology Reports. 35(1). 352–358. 11 indexed citations
20.
Kass, David H., et al.. (1993). Examination of DNA methylation of chromosomal hot spots associated with breast cancer.. PubMed. 13(5A). 1245–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruoqin Wang Breakdown of academic impact, for papers by Francesca Maria Consonni Breakdown of academic impact, for papers by Umar Raza Breakdown of academic impact, for papers by Chunping Qiu Breakdown of academic impact, for papers by Xinzhou Deng Breakdown of academic impact, for papers by Peter Breslin Breakdown of academic impact, for papers by Bethany Smith Breakdown of academic impact, for papers by Xiaoqian Jing Breakdown of academic impact, for papers by Chuanyong Zhang
Rankless by CCL
2026